Pulmonary Manifestations of Inflammatory Bowel Disease in Children

Cureus. 2020 Nov 7;12(11):e11369. doi: 10.7759/cureus.11369.

Mark A Taylor 2nd 1, Holly Zhou 2, David M Dansie 3, Scott Short 1


Author information

  • 1Department of Surgery, University of Utah, Salt Lake City, USA.
  • 2Department of Pathology, University of Utah, Salt Lake City, USA.
  • 3Department of Radiology, Primary Children's Hospital, Salt Lake City, USA.


The recognition of pulmonary manifestations of inflammatory bowel disease (IBD) is important as these diseases can be confused with infectious etiologies (e.g., tuberculosis or fungal infection) and, as a result, may unnecessarily delay institution of appropriate therapy (e.g., infliximab). Furthermore, they are a source of morbidity that may be overlooked and, like other IBD-related pathologies, are often responsive to treatment with corticosteroids, immunomodulators, or biologic therapies. The purpose of this paper is to describe the cases of six children at a single institution with differing presentations, treatments, and responses to treatment of their IBD-related lung disease to improve recognition of this uncommon process.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.